Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial - Takeaways - MDSpire

Evaluation of a Digital Health Intervention Following Percutaneous Coronary Intervention: Results from a Randomized Controlled Study

  • By

  • Elias Freyr Gudmundsson

  • Bartosz Dobies

  • Brynja Laxdal

  • Inga Valborg Olafsdottir

  • Ingibjörg Davidsdottir

  • Heida Birna Bragadottir

  • Svala Sigurdardottir

  • Ari Pall Isberg

  • Andrew Grannell

  • Berglind Libungan

  • Brynjolfur A. Mogensen

  • Hulda Halldorsdottir

  • Maria V. Gudmundsdottir

  • Bylgja Kaernested

  • Tryggvi Thorgeirsson

  • Saemundur Jon Oddsson

  • David O. Arnar

  • July 21, 2026

Share

  • 1

    The study evaluated a digital health intervention (SK-121) alongside standard care to reduce recurrent cardiovascular events post-PCI.

  • 2

    Two hundred patients were randomized to receive either standard care alone or standard care plus a 48-week gamified digital program.

  • 3

    The intervention did not significantly change the SMART2 risk score at 6 months, with an adjusted mean difference of -0.3% (P = 0.821).

  • 4

    Participants in the intervention group showed significant improvements in disease knowledge, medication adherence, and diastolic blood pressure.

  • 5

    In overweight participants, the intervention significantly reduced SMART2 scores at 12 months compared to controls (P = 0.033).

Original Source(s)

Related Content